BOXED O
WARNING O
: O
WARNING O
: O
RISK O
OF O
SERIOUS O
DEHYDRATION O
IN O
PEDIATRIC O
PATIENTS O
WARNING O
: O
RISK O
OF O
SERIOUS O
DEHYDRATION O
IN O
PEDIATRIC O
PATIENTS O
* O
LINZESS O
is O
contraindicated O
in O
patients O
less O
than O
6 O
years O
of O
age O
; O
in O
nonclinical O
studies O
in O
neonatal O
mice O
, O
administration O
of O
a O
single O
, O
clinically O
relevant O
adult O
oral O
dose O
of O
linaclotide O
caused O
deaths B-NonOSE_AE
due O
to O
dehydration B-NonOSE_AE
[ O
see O
Contraindications O
( O
4 O
) O
, O
Use O
in O
Specific O
Populations O
( O
8.4 O
) O
] O
. O

* O
Avoid O
use O
of O
LINZESS O
in O
patients O
6 O
years O
to O
less O
than O
18 O
years O
of O
age O
[ O
see O
Warnings O
and O
Precautions O
( O
5.1 O
) O
, O
Use O
in O
Specific O
Populations O
( O
8.4 O
) O
] O
. O

* O
The O
safety O
and O
effectiveness O
of O
LINZESS O
have O
not O
been O
established O
in O
patients O
less O
than O
18 O
years O
of O
age O
[ O
see O
Use O
in O
Specific O
Populations O
( O
8.4 O
) O
] O
. O

EXCERPT O
: O
WARNING O
: O
RISK O
OF O
SERIOUS O
DEHYDRATION O
IN O
PEDIATRIC O
PATIENTS O
See O
full O
prescribing O
information O
for O
complete O
boxed O
warning O
. O

* O
LINZESS O
is O
contraindicated O
in O
patients O
less O
than O
6 O
years O
of O
age O
; O
in O
neonatal O
mice O
, O
linaclotide O
caused O
deaths O
due O
to O
dehydration O
. O

( O
4 O
, O
8.4 O
) O
* O
Avoid O
use O
of O
LINZESS O
in O
patients O
6 O
years O
to O
less O
than O
18 O
years O
of O
age O
. O

( O
5.1 O
, O
8.4 O
) O
* O
The O
safety O
and O
effectiveness O
of O
LINZESS O
have O
not O
been O
established O
in O
patients O
less O
than O
18 O
years O
of O
age O
( O
8.4 O
) O
. O

